Best Stocks : Mattel, Inc. (NASDAQ:MAT), Weatherford International plc (NYSE:WFT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), General Electric Company (NYSE:GE), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

On Oct 17, Mattel, Inc. (NASDAQ:MAT), posted profit that trailed analysts’ estimates as sales of Barbie dolls dropped for a fourth straight quarter. Third-quarter net income shrank 22 percent to $331.8 million, or 97 cents a share, from $422.8 million, or $1.21, the El Segundo, California-based company said today in a statement. Analysts had predicted $1.02 a share, on average, based on 12 estimates compiled … Continue reading Best Stocks : Mattel, Inc. (NASDAQ:MAT), Weatherford International plc (NYSE:WFT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), General Electric Company (NYSE:GE), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

Moving Stocks : eBay Inc. (NASDAQ:EBAY), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), KBR, Inc. (NYSE:KBR), Tenet Healthcare Corp. (NYSE:THC), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)

EBay Inc. (NASDAQ:EBAY) said on September 30 that it would separate its PayPal digital-payments unit and marketplace business into two companies by the end of next year. eBay Inc. (NASDAQ:EBAY) belongs to Services sector. Its net profit margin is -0.70% and weekly performance is -6.46%. On last trading day company shares ended up $52.97. eBay Inc. (NASDAQ:EBAY) distance from 50-day simple moving average (SMA50) is … Continue reading Moving Stocks : eBay Inc. (NASDAQ:EBAY), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), KBR, Inc. (NYSE:KBR), Tenet Healthcare Corp. (NYSE:THC), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)

Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

Agenus Inc. (NASDAQ:AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus Inc. (NASDAQ:AGEN) stock performance was 0.00% in last session and finished the day at $4.89. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 1.12 million shares. The beta of the stock remained 1.33. … Continue reading Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

Top Movers: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Kingtone Wirelessinfo Solution Holding Ltd. (NASDAQ:KONE), Adobe Systems Incorporated (NASDAQ:ADBE), Facebook Inc (NASDAQ:FB), UDR, Inc. (NYSE:UDR)

BTIG Research assumed coverage on shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) in a research note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $5.50 price target on the stock. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) belongs to Healthcare sector. Its weekly performance is -4.64%. On last trading day company shares ended up $2.57. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) distance from 50-day simple … Continue reading Top Movers: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Kingtone Wirelessinfo Solution Holding Ltd. (NASDAQ:KONE), Adobe Systems Incorporated (NASDAQ:ADBE), Facebook Inc (NASDAQ:FB), UDR, Inc. (NYSE:UDR)

5 Active Stocks: DR Horton Inc. (NYSE:DHI), SouFun Holdings Ltd. (NYSE:SFUN), SAExploration Holdings, Inc. (NASDAQ:SAEX), Synergetics USA, Inc. (NASDAQ:SURG), Sunesis Pharmaceuticals (NASDAQ:SNSS)

D.R. Horton (NYSE:DHI) has earned a consensus rating of “Hold” from the fifteen brokerages that are covering the stock, Analyst Ratings Net reports. Nine investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. DR Horton Inc. (NYSE:DHI) belongs to Industrial Goods sector. Its net profit margin is … Continue reading 5 Active Stocks: DR Horton Inc. (NYSE:DHI), SouFun Holdings Ltd. (NYSE:SFUN), SAExploration Holdings, Inc. (NASDAQ:SAEX), Synergetics USA, Inc. (NASDAQ:SURG), Sunesis Pharmaceuticals (NASDAQ:SNSS)